Immunogenicity was assessed by hemagglutination-inhibition (HI) prevaccination and 28 days after each vaccination. Immunogenic non-inferiority QIV versus TIV for shared strains, and superiority ...
The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings ...
2 天
Clinical Trials Arena on MSNAC Immune reports interim outcomes from trial of Parkinson’s therapyAC Immune has reported additional interim safety and positive immunogenicity outcomes from its placebo-controlled Phase II ...
A new article in the journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration ...
So, what is the adjuvant element that stimulates immunogenicity and makes these vaccines successful? Ishii and colleagues now reveal that TBK1 (TANK-binding kinase 1) mediates the adjuvant effect ...
Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the ...
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active ...
Presentation Details Title: Safety and Immunogenicity of PIV5-Vectored RSV Intranasal Vaccine (BLB201) in Healthy Adults and Children Date/Time: March 13, 2025 / 8:30 am to 8:45 am (GMT-3 ...
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...
Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果